Novacyt gearing up for hearing in DHSC litigation
19th Apr 2024 11:02
(Sharecast News) - Molecular diagnostics specialist Novacyt updated the market on legal proceedings between itself and its subsidiary Primer Design against the Department of Health and Social Care (DHSC) on Friday.
Read moreNovacyt confirms end of Yourgene Taiwan disposal discussions
6th Feb 2024 12:48
(Sharecast News) - Novacyt announced on Tuesday that it had received formal notification from INEX Innovate terminating discussions around the acquisition of Yourgene Health Taiwan.
Read moreNovacyt taps Steve Gibson for CFO
2nd Jan 2024 08:12
(Sharecast News) - Biotechnology group Novacyt has appointed Steve Gibson to the role of chief financial officer with immediate effect.
Read moreNovacyt facing delays in disposal of Yourgene Taiwan
21st Dec 2023 15:49
(Sharecast News) - Molecular diagnostics company Novacyt updated the market on the conditional disposal of its laboratory in Taiwan, which it acquired as part of its purchase of Yourgene Health on 8 September.
Read moreNovacyt to buy Yourgene Health in £16.7m deal
3rd Jul 2023 09:07
(Sharecast News) - Yourgene Health surged on Monday after it agreed to be bought by Novacyt in a £16.7m deal.
Read moreUK regulator approves Novacyt Covid-19 test
6th Dec 2022 12:29
(Sharecast News) - Shares in clinical diagnostics specialist Novacyt sparked on Tuesday, after the UK regulator approved its latest Covid-19 test.
Read moreNovacyt's exsig receives UK approval
15th Jul 2022 08:43
(Sharecast News) - Clinical diagnostics group Novacyt's exsig Covid-19 Direct Real-Time PCR test has received approval from the UK's Health Security Agency.
Read moreNovacyt gets another Covid-19 test approved in the UK
17th Feb 2022 15:38
(Sharecast News) - Clinical diagnostics company Novacyt announced on Thursday that its 'PROmate' Covid-19 2G Real-Time PCR test had been approved in the UK, under the UK Health Security Agency's coronavirus test device approvals (CTDA) regulations.
Read moreNovacyt gets UK approval for 'genesig' Covid-19 test
26th Nov 2021 08:02
(Sharecast News) - Clinical diagnostics specialist Novacyt announced on Friday thatots 'genesig' Covid-19 real-time PCR test has been approved in the UK.
Read moreNovacyt flags possible £3m hit from Covid test regulations change
2nd Nov 2021 11:45
(Sharecast News) - Clinical diagnostics specialist Novacyt updated the market on the availability of its Covid-19 tests in the UK on Tuesday, following the implementation of amendments to the UK Health Security Agency's coronavirus test device regulations, or 'CTDA'.
Read moreNovacyt launches new 'Winterplex' test, lateral flow tests delayed
30th Sep 2021 09:37
(Sharecast News) - Clinical diagnostics specialist Novacyt issued a research and development update on Thursday, including the launch of a new CE-marked 'Winterplex' polymerase chain reaction (PCR) test to diagnose Covid-19, respiratory syncytial virus (RSV) and types of influenza.
Read moreNovacyt swings to first-half loss amid DHSC dispute
27th Sep 2021 08:15
(Sharecast News) - Clinical diagnostics specialist Novacyt reported group consolidated unaudited revenue of £54m in its first half on Monday, down from £63.3m year-on-year, which excluded £40.8m of Department of Health and Social Care (DHSC) revenues, while that contract dispute continued.
Read moreNovacyt FY revenues potentially 'materially affected' by outcome of DHSC dispute
16th Sep 2021 11:05
(Sharecast News) - Biotechnology company Novacyt warned on first-half revenues on Thursday as a result of its ongoing dispute with the US Department of Health and Social Care.
Read moreFirst half revenues up more than 50pc for Novacyt
18th Aug 2021 10:12
(Sharecast News) - Novacyt said in an update on Wednesday that unaudited revenue in its first half was ahead more than 50% year-on-year, at £94.7m.
Read moreNovacyt appoints David Allmond as new chief executive
29th Jul 2021 15:31
(Sharecast News) - Clinical diagnostics specialist Novacyt announced the appointment of David Allmond as its new chief executive officer and a member of its board on Thursday, effective from 18 October.
Read more